Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-Severe Plaque Psoriasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT05272150
What this trial is testing

Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp Psoriasis

Who this might be right for
Plaque PsoriasisScalp Psoriasis
Janssen Research & Development, LLC 211
Large-scale testing (Phase 3)Study completedNCT01241591
What this trial is testing

A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 1,101
Large-scale testing (Phase 3)Study completedNCT01726933
What this trial is testing

LAS41008 in Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Almirall, S.A. 839
Large-scale testing (Phase 3)Study completedNCT02362789
What this trial is testing

Secukinumab Study in PSOriasis Exploring pruRITUS Intensity and Lesional Biomarkers

Who this might be right for
Psoriasis
Novartis Pharmaceuticals 132
Large-scale testing (Phase 3)UnknownNCT06110676
What this trial is testing

Evaluate the Efficacy and Safety of LZM012

Who this might be right for
Psoriasis
Livzon Pharmaceutical Group Inc. 918
Large-scale testing (Phase 3)Study completedNCT03875482
What this trial is testing

Assess Safety and Efficacy of Risankizumab Using a New Formulation in Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie 157
Early research (Phase 1)Ended earlyNCT02502188
What this trial is testing

Phase 1 Study of CC-90005 in Healthy Subjects and Subjects With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
ParapsoriasisHealthy Volunteers
Celgene 24
Not applicableStudy completedNCT01077232
What this trial is testing

Documentation of Humira in Psoriasis Patients in Routine Clinical Practice

Who this might be right for
Moderate to Severe Plaque Psoriasis
AbbVie (prior sponsor, Abbott) 5,442
Large-scale testing (Phase 3)Study completedNCT00710580
What this trial is testing

Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
AbbVie (prior sponsor, Abbott) 350
Large-scale testing (Phase 3)Study completedNCT04761627
What this trial is testing

Investigate Interchangeability of ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 494
Post-approval studies (Phase 4)Study completedNCT00940862
What this trial is testing

Effect of Adalimumab on Vascular Inflammation in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
PsoriasisVascular InflammationCoronary Atherosclerosis
Innovaderm Research Inc. 30
Large-scale testing (Phase 3)Study completedNCT00338754
What this trial is testing

Adalimumab in Adult Japanese Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Abbott 160
Testing effectiveness (Phase 2)Study completedNCT00606450
What this trial is testing

Double-Blind, Randomized, Placebo-controlled Comparison of CC-10004 in Subjects With Moderate to Severe Plaque Type Psoriasis

Who this might be right for
Psoriasis
Amgen 260
Testing effectiveness (Phase 2)Study completedNCT06278350
What this trial is testing

Evaluate the Efficacy and Safety of D-2570 in Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
InventisBio Co., Ltd 161
Testing effectiveness (Phase 2)Study completedNCT03706209
What this trial is testing

Study to Evaluate Efficacy and Safety of MP1032 in Patients With Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
MetrioPharm AG 155
Not applicableStudy completedNCT00096928
What this trial is testing

Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE)

Who this might be right for
Psoriasis
Genentech, Inc. 1,846
Large-scale testing (Phase 3)Study completedNCT06122649
What this trial is testing

Investigate Efficacy and Safety of Apremilast 30 mg Twice Daily (BID) in Chinese Participants With Moderate to Severe Plaque-type Psoriasis (PsO)

Who this might be right for
Plaque Psoriasis
Amgen 203
Large-scale testing (Phase 3)Study completedNCT03410992
What this trial is testing

A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque PsoriasisModerate to Severe Chronic Plaque PsoriasisPsoriatic Arthritis
UCB Biopharma SRL 435
Testing effectiveness (Phase 2)Study completedNCT01043393
What this trial is testing

Desoximetasone Spray 0.25%, Hypothalamic Pituitary Adrenal (HPA) Axis Study

Who this might be right for
Psoriasis
Sun Pharmaceutical Industries, Inc. 24
Large-scale testing (Phase 3)Not Yet RecruitingNCT06844799
What this trial is testing

HS-20137 in Participants with Moderate-to-severe Plaque Psoriasis

Who this might be right for
Moderate-to-severe Plaque Psoriasis
Hansoh BioMedical R&D Company 720
Next Page